Document is current
Any future updates will be listed below
-
Authors
Mehr, Samuel
Hauke, Ralph
-
Funding
Funding for this research was provided by:
Bayer US
- License Information
-
More Information
Article History
Received: 26 March 2025
Accepted: 26 August 2025
First Online: 8 October 2025
Declarations
:
: Samuel Mehrreports payments for professional services from Cellectar Biosciences, Novartis, Bayer, Blue Earth Therapeutics, RayzeBio, Perspective Therapeutics, Spectrum Pharmaceuticals and Siemens Healthineers. Ralph Hauke reports payment for expert testimony from TeleDoc; leadership or fiduciary roles with ASCO, Midwest Private Practice Associates ACO, and the Nebraska Oncology Society; and having served on advisory committees to AstraZeneca.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.
